Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer

被引:0
|
作者
Hong, Sa Deok [1 ]
Katuwal, Nar Bahadur [1 ]
Kang, Min Sil [1 ]
Ghosh, Mithun [1 ]
Park, Seong Min [1 ]
Kim, Tae Hoen [2 ]
Baek, Young Seok [1 ,3 ]
Lee, Seung Ryeol [4 ]
Moon, Yong Wha [5 ]
机构
[1] CHA Univ, Grad Sch, Dept Biomed Sci, Seongnam 13488, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Dept Pathol, Seongnam 13496, South Korea
[3] CHA Biotech, R&D Div, Immunotherapy Team, New Biol Ent NBE Res, Seongnam Si 13488, South Korea
[4] CHA Univ, CHA Bundang Med Ctr, Dept Urol, Seongnam Si 13496, South Korea
[5] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Div Hematol Oncol, Seongnam Si 13496, South Korea
基金
新加坡国家研究基金会;
关键词
HER2-overexpressed ovarian cancer; trastuzumab; NK cell; ADCC; BREAST-CANCER; FC-RECEPTORS; THERAPY; MECHANISMS; RESISTANCE; HER2;
D O I
10.3390/ijms252111733
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian cancer is the deadliest gynecologic cancer. Although human epidermal growth factor receptor-2 (HER2) overexpression, a poor prognostic molecular marker in ovarian cancer, is found in almost 30% of ovarian cancer cases, there are no established therapies for HER2-overexpressing ovarian cancer. In this study, we investigated the efficacy of combined samfenet, a biosimilar compound of trastuzumab, and natural killer (NK) cells in preclinical model of HER2-overexpressing ovarian cancer. Firstly, we screened the HER2 expression in three ovarian cancer cell lines and eight ovarian cancer patient-derived tumor xenograft (PDTX) samples. Then, immunohistochemistry and silver in situ hybridization (SISH) were performed following clinical criteria. HER2-overexpressing cells exhibited the highest sensitivity to samfenet compared with low-HER2-expressing cells. In addition, the combination of samfenet with natural killer (NK) cells resulted in significantly enhanced sensitivity to HER2-overexpressing cells and showed a significant antitumor effect on PDTX mice compared with monotherapy. It is known that anti-HER2-humanized IgG1 monoclonal antibodies, including trastuzumab, induce antibody-dependent cellular cytotoxicity (ADCC). Consequently, the combination of samfenet with NK cells demonstrated NK cell-mediated ADCC, as confirmed using an in vitro NK cytotoxicity assay and in vivo antitumor efficacy. A transferase dUTP nick end labeling (TUNEL) assay using xenografted tumors further supported the ADCC effects based on the increase in the number of apoptotic cells in the combination group. Furthermore, high HER2 expression was associated with shorter progression-free survival and overall survival based on public mRNA expression data. In this study, we demonstrated that the combination of samfenet and NK cell therapy could be a promising treatment strategy for patients with HER2-overexpressing ovarian cancer, through ADCC effects. Therefore, this study supports a rationale for further clinical studies of the combination of samfenet and NK cells as a therapy for patients with HER2-overexpressing ovarian cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines
    Collins, Denis M.
    Gately, Kathy
    Hughes, Clare
    Edwards, Connla
    Davies, Anthony
    Madden, Stephen F.
    O'Byrne, Kenneth J.
    O'Donovan, Norma
    Crown, John
    CELLULAR IMMUNOLOGY, 2017, 319 : 35 - 42
  • [2] Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
    Collins, D. M.
    O'Donovan, N.
    McGowan, P. M.
    O'Sullivan, F.
    Duffy, M. J.
    Crown, J.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1788 - 1795
  • [3] Paclitaxel Enhances Antibody-dependent Cell-mediated Cytotoxicity of Trastuzumab by Rapid Recruitment of Natural Killer Cells in HER2-positive Breast Cancer
    Miura, Daishu
    Yoneyama, Kimiyasu
    Furuhata, Yoshiaki
    Shimizu, Kazuo
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (04) : 211 - 220
  • [4] Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    Tang, Jennifer J. -J.
    Sung, Alexander P.
    Guglielmo, Michael J.
    Navarrete-Galvan, Lydia
    Redelman, Doug
    Smith-Gagen, Julie
    Hudig, Dorothy
    ANTIBODIES, 2020, 9 (04) : 1 - 18
  • [5] Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
    Beelen, Nicky A.
    Ehlers, Femke A., I
    Bos, Gerard M. J.
    Wieten, Lotte
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (04) : 797 - 804
  • [6] Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
    Collins, Denis M.
    Madden, Stephen F.
    Gaynor, Nicola
    AlSultan, Dalal
    Le Gal, Marion
    Eustace, Alex J.
    Gately, Kathy A.
    Hughes, Clare
    Davies, Anthony M.
    Mahgoub, Thamir
    Ballot, Jo
    Toomey, Sinead
    O'Connor, Darran P.
    Gallagher, William M.
    Holmes, Frankie A.
    Espina, Virginia
    Liotta, Lance
    Hennessy, Bryan T.
    O'Byrne, Kenneth J.
    Hasmann, Max
    Bossenmaier, Birgit
    O'Donovan, Norma
    Crown, John
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 807 - 818
  • [7] Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma
    Nakamura, Ayano
    Suzuki, Susumu
    Kanasugi, Jo
    Ejiri, Masayuki
    Hanamura, Ichiro
    Ueda, Ryuzo
    Seto, Masao
    Takami, Akiyoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [8] Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
    Petricevic, Branka
    Laengle, Johannes
    Singer, Josef
    Sachet, Monika
    Fazekas, Judit
    Steger, Guenther
    Bartsch, Rupert
    Jensen-Jarolim, Erika
    Bergmann, Michael
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [9] Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus
    Aicheler, Rebecca J.
    Wang, Eddie C. Y.
    Tomasec, Peter
    Wilkinson, Gavin W. G.
    Stanton, Richard J.
    ANTIBODIES, 2013, 2 (04): : 617 - 635
  • [10] A novel Ebola virus antibody-dependent cell-mediated cytotoxicity (Ebola ADCC) assay
    Singh, Karnail
    Marasini, Bishal
    Chen, Xuemin
    Spearman, Paul
    JOURNAL OF IMMUNOLOGICAL METHODS, 2018, 460 : 10 - 16